Home » Kearny Venture Partners

Skip to content

FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

Search for:

Facebook
Twitter
Linkedin

Navigation

Site navigation

USA
UK
Germany
Canada
China
Russia
India
France
Italy
NFT

Home
Kearny Venture Partners

Kearny Venture Partners

healthcare

USA

Biopharmaceutical Company Aerpio Pharmaceuticals Raises $40M

Published on March 16, 2017By FinSMEs

funding Start Up USA venture capital

Aerpio Therapeutics Closes $22M Financing

Published on April 23, 2014By FinSMEs

funding Start Up USA venture capital

ViewRay Secures $30M

Published on December 17, 2013By FinSMEs

funding USA venture capital

TriVascular Closes $40M Series E Equity Financing

Published on November 18, 2013By FinSMEs

funding Start Up USA venture capital

Aerpio Therapeutics Completes $9M in Series A Funding

Published on November 6, 2013By FinSMEs

funding Start Up USA venture capital

Boreal Genomics Completes $18M Series C Financing

Published on October 5, 2013By FinSMEs

funding Start Up USA venture capital

Akebia Therapeutics Completes $41M Series C Financing

Published on June 4, 2013By FinSMEs

funding Start Up USA venture capital

Aerpio Therapeutics Closes $27M Series A Financing

Published on August 30, 2012By FinSMEs

funding USA venture capital

TriVascular Secures $60M in Series D Financing

Published on June 4, 2012By FinSMEs

funding USA venture capital

ViewRay Closes $45M Series C Venture Capital Financing

Published on March 13, 2012By FinSMEs

funding USA venture capital

Akebia Therapeutics Raises $4.1M in Series B Financing

Published on January 9, 2012By FinSMEs

funding USA venture capital

Akebia Therapeutics Closes $22M Series B Financing

Published on April 27, 2011By FinSMEs

The Daily Deal Newsletter – Sign Up

Email address:

Leave this field empty if you're human:

About | Advertise | Contact | Terms & Conditions | Disclaimer | News | The Daily Deal Newsletter

Privacy Policy FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: [email protected]

Follow FinSMEs on:

Sign-up now to the Daily Newsletter